A new study out of England found the risk of Long COVID to be lower with the Omicron variant compared to Delta. That’s good news, but there are some caveats. Andy chats with one of the researchers behind the study, Dr. Claire Steves, who breaks down the risk of Long COVID based on age and vaccination status. Benjamin Mazer joins to discuss why the population of Americans experiencing Long COVID remains largely unseen, and why the amount of quality data from the U.K. on Long COVID far surpasses the U.S.

Keep up with Andy on Twitter @ASlavitt.

Follow Dr. Claire Steves and Benjamin Mazer on Twitter @DrClaireSteves and @BenMazer.

Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium. 

Support the show by checking out our sponsors!

• Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/ 

Check out these resources from today’s episode: 

• Read Claire’s report out England that found the risk of Long COVID to be lower with the Omicron variant compared to Delta: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00941-2/fulltext
• Read Ben’s piece on why the population of American experiencing Long COVID remains largely unseen: https://www.theatlantic.com/health/archive/2022/06/long-covid-chronic-illness-disability/661285/
• Find vaccines, masks, testing, treatments, and other resources in your community: https://www.covid.gov/
• Order Andy’s book, “Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response”: https://us.macmillan.com/books/9781250770165 

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia. 

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.